Showing results (581-590 of 1,142) with videos related to

Sort By:
Pageof 115
The Australian and New Zealand Journal of Psychiatry|March 17, 2025
It is time to reassess reporting of electroconvulsive therapy data in New Zealand: A 17-year retrospective analysis of treatment data from WaikatoRobert M Lundin, Savani Kannangara, Matthew Jenkins, et al.
Psychological Medicine|July 25, 2023
Distress, burden, and wellbeing in siblings of people with mental illness: a mixed studies systematic review and meta-analysisAnuradhi Jayasinghe, Anna Wrobel, Kate Filia, et al.
Clinical Psychology Review|January 28, 2017
Towards recovery-oriented psychosocial interventions for bipolar disorder: Quality of life outcomes, stage-sensitive treatments, and mindfulness mechanismsGreg Murray, Nuwan D Leitan, Neil Thomas, et al.
Psychiatry Research|December 23, 2022
A preliminary investigation of the clinical and cognitive correlates of circulating vitamin D in bipolar disorderTamsyn E Van Rheenen, Elysha Ringin, James A Karantonis, et al.
Bipolar Disorders|September 12, 2007
The Bipolar Depression Rating Scale (BDRS): its development, validation and utilityMichael Berk, Gin S Malhi, Catherine Cahill, et al.
Depression and Anxiety|January 13, 2016
SPECIFIC MOOD SYMPTOMS CONFER RISK FOR SUBSEQUENT SUICIDAL IDEATION IN BIPOLAR DISORDER WITH AND WITHOUT SUICIDE ATTEMPT HISTORY: MULTI-WAVE DATA FROM STEP-BDJonathan P Stange, Evan M Kleiman, Louisa G Sylvia, et al.
The Medical Journal of Australia|November 6, 2014
Treatment of bipolar depressionMichael Berk, Lesley Berk, Christopher G Davey, et al.
Calcified Tissue International|February 15, 2018
Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in MenLana J Williams, Michael Berk, Jason M Hodge, et al.
The International Journal of Neuropsychopharmacology|August 29, 2022
The Impact of Posttraumatic Stress Disorder on Pharmacologic Intervention Outcomes for Adults With Bipolar Disorder: A Systematic ReviewSamantha E Russell, Anna L Wrobel, David Skvarc, et al.
Pharmacological Research|June 13, 2021
The endocannabinoidome in neuropsychiatry: Opportunities and potential risksGerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pageof 115